


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
RCUS
Arcus Biosciences
$21.04
Strengths

Upgraded on attractively valued
RCUS Price Performance
$21.86 (-3.75%)
$20.35 (+3.39%)
$12.19 (+72.60%)
$10.96 (+91.97%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
RCUS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RCUS Street Sentiment is extremely bullish and have positive views on the near-term outlook
RCUS has Low risk level
Risks Indicators

High volatilty

Average key support and resistance price levels
What is RCUS current stock price?
What are RCUS stock strengths?
What is RCUS Risk Level?
What is RCUS market cap and volume?
What is RCUS current Stock IQ?
Should I buy RCUS stock right now?
Is RCUS a Strong Buy right now?
What does a 'Strong Buy' rating mean for RCUS?
What does a 'Strong Sell' rating mean for RCUS?
What factors influence RCUS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+11.78%
-6.36%
+3.34%
+6.85%
RCUS
Arcus Biosciences
Current Price
$21.04
Stock Insights
Strengths

Upgraded on attractively valued
Recently Viewed
RCUS
Arcus Biosciences
21.04
-3.44%
MMM
3M Company
153.16
-2.03%
DHR
Danaher
218.89
-0.33%
RELI
Reliance Global Group
530.00
-0.93%
CLGN
CollPlant Biotechnol
1.88
-1.36%

RCUS Price Performance
$21.86 (-3.75%)
$20.35 (+3.39%)
$12.19 (+72.60%)
$10.96 (+91.97%)
RCUS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
RCUS Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RCUS Street Sentiment is extremely bullish and have positive views on the near-term outlook
RCUS has Low risk level
Risks Indicators

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 14, 2026
Upgrade
Buy
Goldman Sachs
Dec 13, 2025
Reiterate
Buy
HC Wainwright & Co.
Nov 29, 2025
Reiterate
Neutral
B of A Securities
Oct 30, 2025
Reiterate
Buy
Citigroup
Oct 21, 2025
Reiterate
Overweight
Wells Fargo
RCUS Stock IQ
RCUS Latest Analysis
Arcus Biosciences Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow.
Fri Jan 16, 2026
Arcus Biosciences Inc. (RCUS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Wed Jan 14, 2026
Goldman Sachs Upgrades Arcus Biosciences (RCUS). Fintel reports that on January 13 2026 Goldman Sachs upgraded their outlook for Arcus Biosciences (NYSE:RCUS) from Neutral to Buy. Analyst Price Forecast Suggests 43.98% Upside
Wed Jan 14, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RCUS Stock trends
RCUS Stock performance
RCUS Stock analysis
RCUS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.